Tumor-derived inflammatory mediators, including IL-6 [91–93] and TNFα [94–98] have causal roles in tissue-specific insulin resistance, including liver, adipose tissue, and skeletal muscle. The gene discussed is IL6; the disease is Insulin resistance.